Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 1345-1356 of 9514

Business Wire logo

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform

Business Wire logo

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform

PR Newswire associated0

IFPA launches first Africa Forum on psoriasis calling for urgent action on overlooked disease

Presswire associated0

LONG-TERM HEAVY CANNABIS USE LINKED TO THINNING IN FRONTAL BRAIN REGION

Business Wire logo

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy

PR Newswire associated0

Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

PR Newswire associated0

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union

PR Newswire associated0

Singclean Global Aesthetic Master Symposium Makes Landmark Debut in Monaco

PR Newswire associated0

Smartee Advances "Mandibular Repositioning" Solutions in the UK with Specialized Clinical Conference in London

PR Newswire associated0

FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR

PR Newswire associated0

Landmark ALL-RISE® Trial Results Presented at ACC.26: CathWorks FFRangio Demonstrates Similar Clinical Outcomes to Invasive Wire-based Physiology Assessment

  • Prev Page
  • 1
  • 2
  • …
  • 112
  • 113
  • 114
  • …
  • 792
  • 793
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us